Our Approach

Indivior is a global pharmaceutical company working to help change patients’ lives by pioneering life-transforming treatment for addiction and other serious mental illnesses.

We manufacture and market medicines for the treatment of moderate to severe opioid use disorder with a global portfolio in over 40 countries. In the United States, Indivior also markets medicine for the treatment of schizophrenia in adults and makes this available through licensing agreement in Canada. 

The patient drives our decisions and our guiding principles foster a culture that seeks to create lasting social value by helping to address one of the most urgent epidemics of our time.   

We work with urgency to achieve our Vision that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction.

 

WE UNDERSTAND
patient needs...

  • We work to normalize addiction as a chronic brain disease
  • We recognize that every patient journey is different
  • We seek to expand access to treatment
  • We pioneer life-transforming treatments

WE TACKLE
global challenges...

  • Opioid use disorder
  • Co-occurring disorders of addiction (schizophrenia)
  • Stigma of addiction
  • Access to treatment

 

Purpose, Vision, Mission and Commitment


Purpose

Indivior’s purpose is to pioneer life-transforming treatment.


Vision

Indivior’s vision is that all patients around the world have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction.


Mission

Indivior’s mission is to be the global leader who is a pioneer in developing innovative prescription treatments to addicted patients.


Commitment

Indivior commits to maintaining a robust and responsible business approach at all times.